步长制药：第五届董事会第三十一次会议决议公告

Group 1 - The core point of the article is that Buchang Pharmaceutical announced the approval of several proposals, including the change of the legal representative of its controlling subsidiary during the 31st meeting of its fifth board of directors [2]